Prescription drugs and medicines for conditions relating to pharmacology and toxicology. Studies in these areas include: diet and nutrition; overdoses; and vitamin deficiencies.
The list of FDA approved drugs for pharmacology and toxicology appears below. Click any link to view the full drug information.
For anesthesia during ophthalmologic procedures
For the prevention of chemotherapy-induced nausea and vomiting
Genetic test for birth defects
Treatment for ethylene glycol poisoning
For the maintenance treatment of opioid dependence
For the treatment of alcohol dependence and the maintenance of alcohol abstinence
For the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate
Treatment for Wilson’s disease
For the reversal of vitamin K antagonist therapy-induced coagulation factor deficiency
Prevention of nausea and vomiting associated with chemotherapy
Treatment for nail fungal infections
Oral tablet to inhibit the hemorrhagic cystitis induced by Ifex (ifosfamide)
For the treatment of opiod-induced constipation in adults with chronic non-cancer pain
For the treatment of congenital or acquired generalized lipodystrophy
Treatment for vitamin B-12 deficiency
Treatment against various bacterias
For the management of acute and chronic moderate to severe pain
Generic equivalent of Percocet and Tylox
Adjunct to general anesthesia during surgical procedures
For the treatment of chemotherapy-induced nausea and vomiting
Oral tablets for the treatment of opiate dependence
quinupristin and dalfopristin for injection
Treatment for bacterial infections
For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function
For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting
The rules of principle for evaluating MediLexicon's FDA pharmacology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The pharmacology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.